Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ID: DRG0UJUZQ)
| ADC Name |
GQ1007
|
|||||
|---|---|---|---|---|---|---|
| Synonyms |
GQ1007
Click to Show/Hide
|
|||||
| Organization |
GeneQuantum Healthcare (Originator);BrightGene Bio-Medical
|
|||||
| Drug Status |
Phase 1 (discontinued)
|
|||||
| Antibody Name |
Anti-HER2 antibody
|
Antibody Info | ||||
| Antigen Name |
Receptor tyrosine-protein kinase erbB-2 (HER2)
|
Antigen Info | ||||
| Payload Name |
TLR7/8 agonist
|
Payload Info | ||||
| Payload Target |
Toll-like receptor 7 (TLR7); Toll-like receptor 8 (TLR8)
|
Target Info | ||||
| Linker Name |
Stable linker
|
Linker Info | ||||
| Conjugate Type |
Enzymatic Catalysis
|
|||||
2027 Update
The disease landscape of This ADC
2027 Update
The clinical trial pipelines of This ADC